Bolton Medical has completed patient enrolment in a Phase I trial designed to evaluate the safety and efficacy of the Treovance abdominal stent-graft with the Navitel delivery system in the endovascular aortic repair of abdominal aortic aneurysms.

The Trevoance abdominal stent-graft offers advantages through its size-range and multiple fixation points, while the Navitel delivery system is equipped with a detachable sheath that allows for controlled or rapid deployment.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Phase I trial includes 30 patients at six centres across the US.

The company plans to conduct a pivotal Phase II trial in 2012.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact